Key facts
- In January 2025, 1 033 measles cases were reported by 17 countries. Eleven countries reported zero cases.
- Through its epidemic intelligence activities, ECDC has identified an additional 1 868 new cases from eight EU countries.
- Overall, four measles-related deaths have been reported in the EU/EEA in 2025, all of them in Romania.
- There has been high measles activity overall in the EU/EEA over the last 12 months; however, the situation varies by country. Some countries have reported large and/or ongoing outbreaks, while others have reported either no sustained transmission or very low transmission.
- Outbreaks associated with imported measles cases have been reported by EU countries.
- Relevant epidemiological updates are available for WHO regions.
Overview
In January 2025, 1 033 measles cases were reported by 17 countries. Eleven countries reported zero cases. In the most recent 12-month period, from 1 February 2024 to 31 January 2025, 30 EU/EEA countries reported a total of 32 265 cases of measles. Between 1 February 2024 and 31 January 2025, of the 29 481 patients with known age, 14 556 (45.1%) were children under five years old and 8 721 (27%) were individuals aged 15 years or above.
The highest notification rates were observed in infants under one year of age (1 052.2 cases per million) and children aged 1-4 years (617.1 cases per million). Of 29 481 cases (100.0% of all cases) with a known age and vaccination status, 25 503 (86.5%) were unvaccinated, 2 583 (8.8%) were vaccinated with one dose of a measles-containing vaccine, 1 304 (4.4%) were vaccinated with two or more doses, and 52 (0.2%) were vaccinated with an unknown number of doses.
Nineteen deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC during the 12-month period, by Romania (18) and Ireland (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance, with data collection conducted on 6 March 2025 from official public sources, identified 1 868 new measles cases since the last monthly report on 10 February 2025.
Since the last monthly report, new cases were reported in eight EU countries: Austria (7), Denmark (1), Germany (15), Ireland (7), the Netherlands (37), Poland (15), Romania (1727) and Spain (59).
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy and EpiPulse. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Austria reported 54 confirmed measles cases in 2025 and as of 5 March 2025, an increase of seven cases since 5 February 2025.
Denmark reported one measles case in 2025 and as of 1 March 2025.
France has reported measles circulation in several regions, including in Hauts-de-France and Auvergne-Rhône-Alpes. Furthermore, a significant increase in imported measles cases has been observed. As of 14 February 2025, 13 measles cases linked to travel to Morocco have been reported. The authorities issued a press statement to raise awareness among travellers to Morocco and to enhance vigilance among healthcare professionals caring for travellers returning from areas where measles is circulating.
Germany reported 41 measles cases in 2025 and as of 5 March 2025, an increase of 15 cases since 10 February 2025.
Ireland reported 36 measles cases in 2025 and as of 1 March 2025, an increase of seven cases since 10 February 2025.
Netherlands reported 63 measles cases in 2025 and as of 5 March 2025, an increase by 37 cases since 6 February 2025. There is no indication of a national outbreak. However, a cluster of measles cases has been detected among children linked to a school, with additional cases reported within households. In 2025, 16 cases were reported to have contracted measles in Morocco and three in Romania. Healthcare professionals in the Netherlands have been advised to be alert to measles in patients who have recently returned from an area where measles is prevalent.
Poland reported 15 measles cases in 2025 and as of 28 February 2025.
Romania reported 2 645 measles cases and four deaths in 2025 and as of 28 February 2025, an increase of 1 727 cases and two deaths since 31 January 2025. The first new death occurred in a two-year-old unvaccinated female, and the second death was in a one-year-old unvaccinated female.
Spain reported 123 measles cases in 2025 and as of 2 March 2025, an increase by 59 cases since 9 February 2025. Of the reported cases, 40 (33%) were imported and 50 (41%) were linked to an imported case. Outbreaks have been reported in several parts of Spain.
On 16 January, the Department of Health of the Basque Government reported a measles outbreak associated with an
imported case in Bizkaia, with 12 confirmed measles cases. According to media reports, the number of cases associated with this outbreak has increased to 50. A large proportion of those affected are healthcare workers.
Epidemiological summary for select countries outside of EU/EEA with relevant epidemic intelligence updates:
Morocco
Morocco is experiencing a significant measles outbreak that began in October 2023 and has spread nationwide. According to media reports citing official sources, 20 086 measles cases, including 3 391 confirmed cases and 37 deaths have been reported in 2025. In total, over 40 000 cases and nearly 150 deaths have been reported since the beginning of the outbreak and as of 5 March 2025. Most deaths occurred in children under five years of age and adults over 37 years of age.
The reasons for the increase in measles cases are not known. The rise in cases might be attributed to declining vaccination rates following the COVID-19 pandemic. However, according to WHO data, the estimated vaccination coverage rate in the country for the first and second doses of measles vaccine was 99% between 2019 and 2023.
Summary of measles cases reported by WHO regional offices
Increased measles activity has been reported globally. The latest report on measles cases from the WHO regional offices, dated 11 February 2025, was already included in the previous monthly measles report. A total of 3 106 measles cases have been reported to the WHO Regional Offices in 2025 and as of 11 February 2025.
Below, we provide a summary by WHO region, complemented by additional data collected through epidemic intelligence activities:
The WHO Regional Office for Europe (WHO/EUROPE) reported 15 measles cases in 2025 as of 11 February 2025, all from the United Kingdom.
The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
The WHO Regional Office for Africa (WHO AFRO) reported 1 469 measles cases in 2025 as of 11 February 2025. The highest numbers of cases were reported from Ethiopia (314), Rwanda (250), Nigeria (219), Uganda (135) and Burkina Faso (108). Between 24 February and 2 March 2025, WHO AFRO reported measles cases from Cameroon, Ethiopia, Guinea, Kenya, and Senegal.
The WHO Regional Office for the Americas (WHO PAHO) reported 268 measles cases, including one death in 2025 as of 28 February 2025. Measles cases were reported from the United States of America (164, including one death), Canada (96, of which 95% were import related), Argentina (4), and Mexico (4). On 28 February 2025, WHO PAHO issued an Epidemiological Alert for measles, calling on Member States to strengthen vaccination, epidemiological surveillance, and rapid response activities.
The WHO Regional Office for South-East Asia (WHO SEARO) reported 1 558 measles cases in 2025 as of 11 February 2025. The highest numbers of cases were reported by India (1 419), Thailand (103) and Nepal (34).
The WHO Regional Office for the Eastern Mediterranean (WHO EMRO) and the WHO Regional Office for the Western Pacific (WHO WPRO) have reported no measles cases in 2025 as of 11 February 2025. However, in the EMRO region, a large measles outbreak has been reported in Morocco, and in the WPRO region, in Vietnam. According to media reports, WHO has assessed the risk of a measles outbreak in Viet Nam as very high.
ECDC assessment
The overall number of measles cases in the EU/EEA increased steadily between June 2023 and March 2024 before decreasing between April 2024 and January 2025. Measles cases may continue to increase in the EU/EEA in the coming months, in line with measles observed seasonality. This is due to reported suboptimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries, as well as a high probability of importation from areas experiencing high circulation. The majority of recently reported cases have acquired the disease within the reported country through community/local transmission, however cases related to international travel have been reported.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries.
As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Healthcare professionals should be fully vaccinated.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with under-served populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.